A citation-based method for searching scientific literature

Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 195



Mariangela Russo, Sandra Misale, Ge Wei, Giulia Siravegna, Giovanni Crisafulli, Luca Lazzari, Giorgio Corti, Giuseppe Rospo, Luca Novara, Benedetta Mussolin, Alice Bartolini, Nicholas Cam, Roopal Patel, Shunqi Yan, Robert Shoemaker, Robert Wild, Federica Di Nicolantonio, Andrea Sartore Bianchi, Gang Li, Salvatore Siena, Alberto Bardelli. Cancer Discov 2016
Times Cited: 167




List of shared articles



Times cited


Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancers.
Alice Boilève, Loïc Verlingue, Antoine Hollebecque, Valérie Boige, Michel Ducreux, David Malka. Expert Opin Investig Drugs 2021
2

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs.
Sun-Young Han. Pharmaceuticals (Basel) 2021
0

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies.
Antonio Russo, Lorena Incorvaia, Umberto Malapelle, Marzia Del Re, Ettore Capoluongo, Bruno Vincenzi, Rita Chiari, Laura Cortesi, Romano Danesi, Ada Maria Florena,[...]. Crit Rev Oncol Hematol 2021
0

The oncogenic roles of NTRK fusions and methods of molecular diagnosis.
Erfan Aref-Eshghi, Fumin Lin, Marilyn M Li, Yiming Zhong. Cancer Genet 2021
0



[NTRK Fusions: A new way of treatment for gastro-intestinal tumor?]
Kaïssa Ouali, Anna Pellat, Romain Cohen, Magali Svrcek, Frédérique Penault-Llorca, Thierry André. Bull Cancer 2020
1


TRK inhibition in soft tissue sarcomas: A comprehensive review.
Tarek Assi, Elie Rassy, Hussein Nassereddine, Fadi Farhat, Fadi El Karak, Joseph Kattan, Marwan Ghosn. Semin Oncol 2020
5